About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04706273

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

This study will confirm device efficacy and safety in the clinical setting after the launch of the GORE® VIABAHN® Endoprosthesis for the treatment of symptomatic peripheral arterial disease in the sup...

Lead sponsor: W.L.Gore & Associates•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

W.L.Gore & Associates

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Symptomatic peripheral arterial disease in superficial femoral artery lesions

Related studies

RECRUITINGPhase 3

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

NCT07223593 · Peripheral Arterial Disease

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

NCT06112171 · Peripheral Arterial Disease

Handgrip Training in Patients With Peripheral Artery Disease

NCT03663777 · Peripheral Arterial Disease

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

NCT07223437 · Peripheral Arterial Disease

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

NCT07497360 · Peripheral Arterial Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 20, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment321

Start dateAug 2016

Last updatedSep 20, 2024

Condition

Peripheral Arterial Disease

Locations shown

Kansai Rousai

Amagasaki, Hyōgo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 20, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions